A Multicenter Retrospective Study Evaluating IL-5-Targeted Biologic Therapies for the Treatment of Asthma and Allergic Bronchopulmonary Aspergillosis in Adults With Cystic FibrosisTake-Home Points

A Multicenter Retrospective Study Evaluating IL-5-Targeted Biologic Therapies for the Treatment of Asthma and Allergic Bronchopulmonary Aspergillosis in Adults With Cystic FibrosisTake-Home Points

Background: Biologic therapies targeting T-helper cell type 2 (Th2) eosinophilic inflammation have been used for difficult-to-treat asthma and allergic bronchopulmonary aspergillosis (ABPA), but safety and efficacy data are limited in the cystic fibrosis (CF) population. Research Question: Are Th2 b...

Full description

Saved in:
Bibliographic Details
Main Authors: Sameer Desai, PhD, Sophia Shen, MD, Zosia Gryz, BSc, Elizabeth Tullis, MD, Anne L. Stephenson, MD, PhD, Bradley S. Quon, MD, MSc
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:CHEST Pulmonary
Subjects:
allergic bronchopulmonary aspergillosis
asthma
benralizumab
cystic fibrosis
mepolizumab
ABPA, Th2
Online Access:http://www.sciencedirect.com/science/article/pii/S2949789225000303
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2949789225000303

Similar Items